
FDA Clears Initiation of COVID-19 Adaptive Platform Trial Developed by ACESO
Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
Learn about the promise of mRNA to prevent and treat endemic diseases in resource-limited areas with the populations who would benefit the most.
We have partnered with the
Flourish Research team and sites for years to build awareness of clinical research in underserved communities in the
United States.
For us, it encompasses our local staff, decades of on-the-ground experience, strong working relationships with stakeholders of all types, cultural competence and a commitment to the region and its people.
We're looking for research-ready sites and investigators interested in being considered for future studies with FHI Clinical.
Press Release
FDA Clears Initiation of COVID-19 Adaptive Platform Trial Developed by ACESO
We envision a world where advances in vaccines and medicines help all people live longer, healthier lives.
Because of our global expertise, responsive approaches and proven solutions, we are two steps ahead, ready to deploy immediately in markets worldwide and able to measure study launch in days rather than weeks.
Reach new markets and access the right patient populations.
Benefit from our unique combination of in-country technical, regulatory and cultural knowledge and an established global presence in Africa, Asia, Europe, Latin America and North America.
By connecting your research strategy with the overarching policy and local communities, we help facilitate communication and engagement efforts for more successful study execution.
As your study needs or the local situation change, we can adapt our processes and workflow. No matter how large or small the project, we remain agile and exact, because your research demands it.
We also invest in our intellectual capital and are experts at rapid start-up and management of complex clinical research at sites diverse in geographic area and research capacity.
Our work complements that of FHI 360, which is grounded in research and science, reinforced by partnerships and focused on strengthening the capacity of individuals, local organizations and national governments.
Together, we can ensure that countries are prepared to respond to threats to
their population’s health.
Initiation of ACESO’s COVID-19 adaptive platform trial (PROTECT-APT) received FDA approval. FHI Clinical is the CRO and IND sponsor across sites internationally
September 13-14, 2023
Attending BioPharm America? Schedule a meeting to chat with members of our team who will be available to talk about your ongoing and future projects
Fully featured CTMS and EDC can provide the visibility into enrollment trends needed to achieve representation in clinical research. Read how we use Oracle Clinical One to view and monitor participant sociodemographics and more.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |